palmitoylethanolamide.com.au
HomeResearchSara 2022

Lipidomics of Cell Secretome Combined with the Study of Selected Bioactive Lipids in an In Vitro Model of Osteoarthritis

Sara Casati, Chiara Giannasi, Stefania Niada, Elena Della Morte, Marica Orioli, Anna T Brini. Stem Cells Transl Med. 2022 Sep 21;11(9):959-970.

Laboratory studyHumans

Design
Laboratory study
Subjects
Human primary articular chondrocytes stimulated with TNF-alpha; secretome from human adipose- and bone marrow-derived mesenchymal stem cells and dermal fibroblasts
Dose used in the study
Not stated in the abstract; palmitoylethanolamide and 2-AG added to cell culture
Duration
Not stated in the abstract
What was measured
Mass spectrometry lipid profile of cell secretome; prostaglandin E2 release, COX-2 expression and nitric oxide production in TNF-alpha-stimulated chondrocytes.

What the authors reported

TNF-alpha raised PGE2 release, and 2-AG raised it further. Palmitoylethanolamide brought PGE2 release down to the level of unstimulated cells, partly blunted COX-2 expression and partially reduced nitric oxide release.

Limits of this study

A cell culture study of human cartilage cells; it cannot show effect in people or animals treated in practice. Funding and conflicts not stated in the abstract.

Source

PubMed 35792075 · doi:10.1093/stcltm/szac045

Entry checked against the abstract on PubMed on 2026-09-22. The dose shown is the dose the researchers used. It is not a recommendation. How to read this page.